骨髓间充质干细胞LAMA4缺失通过PI3K/Akt通路促进急性髓系白血病阿糖胞苷耐药的机制OA
Mechanism underlying LAMA4 deficiency in bone marrow mesenchymal stem cells promoting cytarabine chemoresistance in acute myeloid leukemia via the PI3K/Akt signaling pathway
目的 探讨骨髓间充质干细胞(MSCs)中层粘连蛋白α4(LAMA4)对急性髓系白血病(AML)细胞阿糖胞苷(Ara-C)化疗敏感性的调控作用及其分子机制.方法 构建LAMA4敲低的MSCs稳定株,与HL-60及MOLM-13两种AML细胞进行Transwell非接触式共培养,结合Ara-C处理,采用CCK-8法检测IC₅₀值,流式细胞术检测细胞凋亡,平板克隆形成实验评估增殖能力,qRT-PCR检测MSCs旁分泌因子和AML细胞耐药基因的表达,Western blot检测PI3K/Akt通路活化水平.采用PI3K特异性抑制剂LY294002进行功能回复实验.结果 LAMA4敲低显著促进MSCs成脂分化,同时上调ANGPT1、ANGPT2、JAG1、KITLG、CXCL12、SPP1等保护性旁分泌因子的转录.与LAMA4敲低MSCs共培养后,AML细胞对Ara-C的IC₅₀值显著升高,凋亡率明显下降,克隆形成能力增强(均P<0.01);耐药相关基因ABCB1、ABCC1、ABCG2及BCL2的mRNA表达上调(P<0.01).同时,LAMA4敲低MSCs共培养可显著增强AML细胞内PI3K和Akt的磷酸化水平(P<0.01).而应用LY294002阻断PI3K/Akt通路后,LAMA4敲低增强的AML耐药表型被部分逆转(P<0.01).结论 MSCs中LAMA4缺失可通过改变其分化特性与旁分泌功能,经PI3K/Akt通路激活AML细胞耐药基因表达,从而促进对Ara-C的化疗耐药.LAMA4是维持骨髓微环境化疗敏感性的保护性分子,靶向LAMA4或PI3K/Akt通路或可为改善AML化疗疗效提供新策略.
Objective This study aims to investigate the regulatory role and molecular mechanism of laminin subunit alpha 4(LAMA4)derived from bone marrow mesenchymal stem cells(MSCs)in modulating the chemosensitivity of acute myeloid leukemia(AML)cells to cytarabine(Ara-C).Methods Stable LAMA4-knockdown MSCs were constructed and co-cultured with two AML cell lines,HL-60 and MOLM-13,via a Transwell-based non-contact co-culture system under Ara-C treatment.The half maximal inhibitory concentration(IC50)was quantified via the Cell Counting Kit-8(CCK-8)assay,the apoptotic rate was detected via flow cytometry,and proliferative capacity was evaluated via the colony formation assay.The expression levels of mesenchymal stem cell(MSC)paracrine factors and AML cell drug resistance-related genes were measured via quantitative reverse transcription-polymerase chain reaction(qRT-PCR).The activation level of the PI3K/Akt signaling pathway was assessed via Western blot.Finally,functional rescue experiments were conducted using the PI3K-specific inhibitor LY294002.Results Knockdown of LAMA4 significantly promoted adipogenic differentiation of MSCs and upregulated the transcription of cytoprotective paracrine factors,including ANGPT1,ANGPT2,JAG1,KITLG,CXCL12,and SPP1.After co-culture with LAMA4-knockdown MSCs,AML cells showed a significantly increased IC50 for Ara-C,a markedly decreased apoptosis rate,and significantly enhanced colony-forming capacity(P<0.01).The mRNA expression of drug resistance-related genes ABCB1,ABCC1,ABCG2,and BCL2 was significantly upregulated(P<0.01).Meanwhile,co-culture with LAMA4-knockdown MSCs elevated the phosphorylation levels of PI3K and Akt in AML cells(P<0.01).Importantly,the enhanced chemoresistance phenotype of AML cells induced by LAMA4 knockdown was partially reversed by pharmacological inhibition of the PI3K/Akt pathway by LY294002(P<0.01).Conclusions Knockdown of LAMA4 in MSCs remodels their differentiation traits and paracrine function.This remodeling induces the upregulation of drug-resistance gene expression in AML cells through activation of the PI3K/Akt signaling pathway,and ultimately promote AML cell chemoresistance to Ara-C.Collectively,these findings indicate that LAMA4 functions as a protective factor that preserves chemosensitivity in the bone marrow microenvironment,and therapeutic targeting of LAMA4 or the PI3K/Akt pathway may yield novel strategies to improve the chemotherapeutic response in AML.
王志伟;吴艳宁;郭宏谋
中国人民解放军联勤保障部队第九八○医院血液科(河北 石家庄 050082)中国人民解放军联勤保障部队第九八○医院血液科(河北 石家庄 050082)中国人民解放军联勤保障部队第九八○医院血液科(河北 石家庄 050082)
医药卫生
急性髓系白血病阿糖胞苷化疗耐药层粘连蛋白α4骨髓间充质干细胞磷脂酰肌醇3-激酶/蛋白激酶B/Akt信号通路
acute myeloid leukemiacytarabinechemoresistancelaminin subunit alpha 4bone marrow mesenchymal stem cellsphosphatidylinositol 3-kinase/protein kinase B signaling pathway
《实用医学杂志》 2026 (19)
3504-3514,11
河北省医学科学研究项目(编号:20231313)
评论